I have both a purity figure and a content figure, which is why the discrepancy is visible.
I am trying to choose between two options that are usually discussed as though only one exists.
I am not optimising for price, but I am not indifferent to it either.
Which axes does this decision turn on?
Concretely, before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
Stated carefully, writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe part that matters: most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
My working rule is that a document without a lot number, a method section and a test date is marketing.
A certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 3 Nov 2025 by stopper_core — clarified the distinction between purity and content
Start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 3 Nov 2025 by loss_on_drying — added the citation requested in comments
What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.